Market Segmentation
- U.S. Molecular Diagnostics Disease Outlook (Revenue in USD Million, 2018 - 2030)
- Healthcare-Associated Infections
- Methicillin-Resistant Staphylococcus aureus
- Staphylococcus aureus
- Enterovirus
- Clostridioides difficile
- Van A
- Sepsis Panel
- Respiratory
- Flu
- Respiratory Syncytial Virus
- Paraflu
- Multidrug-Resistant Tuberculosis
- Mycobacterium Avium-Intracellulare
- Group A Streptococcal
- Adenovirus
- Human Metapneumovirus
- Rhinoviruses
- Middle East Respiratory Syndrome Coronavirus
- Tuberculosis
- Severe Acute Respiratory Syndrome Coronavirus 2
- Human Bocavirus-Infection
- Bordetella
- Mycoplasma Pneumonia
- Respiratory Panels
- Gastrointestinal
- Norovirus
- Helicobacter pylori
- Shiga toxin
- GI Parasite Panel
- GI Bacterial Panel
- GI Viral Panel
- GI Panels
- Women’s Health/STI
- Chlamydia trachomatis (CT)/Neisseria gonorrhoeae (NG)
- Trichomonas Vaginalis
- Mycoplasma Genitalium
- Human Papillomavirus
- Bacterial Vaginosis
- Gonorrhoea Colloquially
- Mycoplasma Genitalium Resistance
- Herpes Simplex Virus
- Group B Streptococcus
- Immunocompromised
- Cytomegalovirus
- Epstein-Barr virus
- Varicella-Zoster Virus
- BK virus
- Virology
- Human immunodeficiency viruses
- Hepatitis C virus
- Hepatitis B virus
- Hepatitis E virus
- Other Targets
- Babesia
- Zika
- West Nile Virus
- chikungunya virus/dengue virus
- Enhancer of zeste homolog 2
- PIK3CA
- Malaria
- Monkeypox Virus
- Other Panels
- Meningitis Panel
- Lyme Panel
- UTI Panel
- Oncology
- Microsatellite Instability
- B-raf
- Epidermal Growth Factor Receptor
- Kirsten RAT SARCOMA VIRUS
- Others
- Healthcare-Associated Infections
- U.S. Molecular Diagnostics End-use Outlook (Revenue in USD Million, 2018 - 2030)
- Hospital Core Laboratory
- Hospital Alternative Sites
- Decentralized Test Sites
- Reference Lab
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2018 to 2030
- Market estimates and forecast for product segments up to 2030
- Regional market size and forecast for product segments up to 2030
- Market estimates and forecast for application segments up to 2030
- Regional market size and forecast for application segments up to 2030
- Company financial performance
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
Brian Moore, VP, NICCA USA, Inc.
testimonialsMore
